Search

everythinglearnresearchcommunity

for

Search:↓

A protein called lfTSLP is important in causing allergic and other skin diseases and could be a target for treatment.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Androgens can both increase and decrease hair growth in different parts of the body.

Methotrexate is a key, cost-effective drug for skin conditions, but requires careful monitoring for side effects.

The effects of estrogen on human hair growth are unclear and need more research.

Hair graying may be caused by stem cell depletion from stress or melanocyte damage.

The document concludes that certain mutations may contribute to the inflammation in hidradenitis suppurativa and suggests that targeting TNFα could be a treatment strategy.

Budesonide and N-acetylcysteine reduced tumors and alopecia in mice, regardless of FHIT gene status.

Keratosis pilaris is often linked to genetic mutations and causes skin and hair abnormalities, regardless of those mutations.

The document concludes that understanding dermal papilla cells is key to improving hair regeneration treatments.

Some cases of folliculotropic mycosis fungoides may progress slowly and not need aggressive treatment.

Deleting Snai2 and Snai3 causes fatal autoimmunity.

FMF and mycosis fungoides are variants of the same disease, and bexarotene can be an effective treatment.

Basaloid follicular hamartoma's appearance can be similar to other skin conditions, and diagnosis should consider both the look and behavior of the tumor.

The report suggests that hair loss in Cronkhite-Canada syndrome may be caused by alopecia areata incognita, as shown by a patient's improvement with treatment.

Tofacitinib was more effective than apremilast in treating hair loss in a mouse model of alopecia areata.

Atopic dermatitis may trigger alopecia areata, and early treatment can help prevent severe cases.

Nrf-2-modified stem cells from hair follicles significantly improve ulcerative colitis in rats.

Dupilumab can both improve and worsen alopecia areata, with higher IgE levels linked to better outcomes.

Vascular endothelial cells may significantly influence skin stem cells, but more research is needed.

A gel from stem cells can reduce baldness caused by fluconazole in rats.

taVNS reduces vitiligo symptoms in mice.

New treatment using engineered nanovesicles in hydrogel improves hair growth by repairing hair follicle cells in a mouse model of hair loss.

NCSTN gene mutation causes abnormal skin cell differentiation and more inflammation, contributing to Hidradenitis Suppurativa.

Folliculotropic mycosis fungoides has a worse prognosis than other types, with survival rates varying significantly based on subtype and organ involvement.

Certain immune markers may predict chemotherapy response in mesothelioma, and nivolumab is a tolerable and effective treatment for advanced non-small cell lung cancer.

Rituximab therapy successfully treated a patient's complete body hair loss and was effective for six years.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

Syphilitic alopecia is a rare hair loss condition in secondary syphilis that looks similar to another condition but can be diagnosed with specific tests and responds to antibiotics.

SMR-2 and SMR-6 are much more toxic than retinoic acid, causing severe symptoms and organ damage in mice.